Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Aye JM"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma.
Autorzy:
Bownes LV; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Marayati R; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Quinn CH; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Beierle AM; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Hutchins SC; Division of Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Julson JR; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Erwin MH; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Stewart JE; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Mroczek-Musulman E; Department of Pathology, Children's of Alabama, Birmingham, AL 35233, USA.
Ohlmeyer M; Atux Iskay LLC, Plainsboro, NJ 08536, USA.
Aye JM; Division of Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Yoon KJ; Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Beierle EA; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2022 Apr 13; Vol. 14 (8). Date of Electronic Publication: 2022 Apr 13.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
Autorzy:
Marayati R; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Stafman LL; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Williams AP; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Bownes LV; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Quinn CH; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Aye JM; Department of Pediatric Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Stewart JE; Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Yoon KJ; Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Anderson JC; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Willey CD; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Beierle EA; Department of Surgery, University of Alabama at Birmingham, 1600 7th Ave. South, Lowder Building, Suite 300, Birmingham, AL, 35233, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 16; Vol. 11 (1), pp. 5984. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Drug Resistance, Neoplasm*/genetics
Antineoplastic Agents/*pharmacology
Cisplatin/*pharmacology
Hepatoblastoma/*metabolism
Liver Neoplasms/*metabolism
Proto-Oncogene Proteins c-pim-1/*metabolism
Animals ; Antineoplastic Agents/therapeutic use ; Apoptosis/drug effects ; Biphenyl Compounds/pharmacology ; Cell Line, Tumor ; Cisplatin/therapeutic use ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Enzyme Activation ; Gene Expression ; Hepatoblastoma/drug therapy ; Hepatoblastoma/etiology ; Hepatoblastoma/pathology ; Humans ; Liver Neoplasms/drug therapy ; Liver Neoplasms/etiology ; Liver Neoplasms/pathology ; Mice ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/metabolism ; Phenotype ; Proto-Oncogene Proteins c-pim-1/genetics ; Thiazolidines/pharmacology ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth.
Autorzy:
Bownes LV; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Williams AP; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Marayati R; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Stafman LL; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Markert H; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Quinn CH; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Wadhwani N; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Aye JM; Division of Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Stewart JE; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Yoon KJ; Division of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Mroczek-Musulman E; Department of Pathology, Children's of Alabama, Birmingham, Alabama, United States of America.
Beierle EA; Division of Pediatric Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Mar 09; Vol. 16 (3), pp. e0246244. Date of Electronic Publication: 2021 Mar 09 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Enhancer of Zeste Homolog 2 Protein/*antagonists & inhibitors
Enzyme Inhibitors/*pharmacology
Neuroblastoma/*pathology
Animals ; Apoptosis/drug effects ; Cell Line, Tumor ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Humans ; Mice ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts.
Autorzy:
Stafman LL; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA.
Williams AP; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA.
Marayati R; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA.
Aye JM; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Alabama, Birmingham, AL, 35233, USA.
Markert HR; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA.
Garner EF; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA.
Quinn CH; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA.
Lallani SB; Department of Cell Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, 35233, USA.
Stewart JE; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA.
Yoon KJ; Department of Pharmacology and Toxicology, University of Alabama, Birmingham, AL, 35233, USA.
Whelan K; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Alabama, Birmingham, AL, 35233, USA.
Beierle EA; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, AL, 35205, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Sep 13; Vol. 9 (1), pp. 13259. Date of Electronic Publication: 2019 Sep 13.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cell Movement*
Cell Proliferation*
Focal Adhesion Kinase 1/*antagonists & inhibitors
Neuroblastoma/*pathology
Quinolones/*pharmacology
Sulfones/*pharmacology
Animals ; Apoptosis ; Cell Cycle ; Child ; Female ; Humans ; Male ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Neoplasm Invasiveness ; Neuroblastoma/drug therapy ; Neuroblastoma/enzymology ; Tumor Cells, Cultured ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł:
PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.
Autorzy:
Stafman LL; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, Birmingham, AL, United States of America.
Williams AP; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, Birmingham, AL, United States of America.
Marayati R; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, Birmingham, AL, United States of America.
Aye JM; Division of Pediatric Hematology Oncology, Department of Pediatrics, University of Alabama, Birmingham, Birmingham, AL, United States of America.
Stewart JE; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, Birmingham, AL, United States of America.
Mroczek-Musulman E; Department of Pathology, University of Alabama, Birmingham, Birmingham, AL, United States of America.
Beierle EA; Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, Birmingham, AL, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Apr 10; Vol. 14 (4), pp. e0214469. Date of Electronic Publication: 2019 Apr 10 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin/*administration & dosage
Hepatoblastoma/*pathology
Liver Neoplasms/*pathology
Protein Phosphatase 2/*metabolism
Animals ; Apoptosis ; Autoantigens/metabolism ; Cell Cycle ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Cell Survival ; DNA-Binding Proteins ; Female ; Fingolimod Hydrochloride/administration & dosage ; Hepatoblastoma/drug therapy ; Histone Chaperones/metabolism ; Humans ; Intracellular Signaling Peptides and Proteins/metabolism ; Liver Neoplasms/drug therapy ; Membrane Proteins/metabolism ; Mice ; Mice, Nude ; Neoplasm Transplantation ; Transcription Factors/metabolism
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies